Investor Relations

Investor Overview

KemPharm uses its LAT platform technology to discover and develop prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety.

 

Stock Quote
KMPH (Common Stock)
PriceChange% ChangeVolume
$4.200.000.00%0
Previous CloseToday's OpenIntraday HighIntraday Low
$4.20$0.00$4.35$3.98
Exchange: NASDAQ (US Dollar)
04/25/17 3:59 p.m. ET
Refresh quote
Recent NewsMore >>
03/27/17
KemPharm to Present at the 2nd Annual Neuroscience Biopartnering and Investment Forum
03/16/17
KemPharm Presents Clinical Data for Opioid Prodrug Candidates at American Academy of Pain Medicine’s Annual Meeting
03/09/17
KemPharm, Inc. Reports Fourth Quarter and Year End 2016 Results
Upcoming EventsMore >>
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources